|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/517 | (2006.01) |
| A61K 47/38 | (2006.01) | ||
| A61K 47/02 | (2006.01) |
| (11) | Number of the document | 1753431 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05744858.1 |
| Date of filing the European patent application | 2005-05-18 | |
| (97) | Date of publication of the European application | 2007-02-21 |
| (45) | Date of publication and mention of the grant of the patent | 2009-08-19 |
| (46) | Date of publication of the claims translation | 2009-11-25 |
| (86) | Number | PCT/GB2005/001931 |
| Date | 2005-05-18 |
| (87) | Number | WO 2005/112934 |
| Date | 2005-12-01 |
| (30) | Number | Date | Country code |
| 0411378 | 2004-05-21 | GB |
| (72) |
STOTT, Paul. William, c/o AstraZeneca, GB
|
| (73) |
Genzyme Corporation,
500 Kendall Street, Cambridge, MA 02142,
US
|
| (74) |
Malvina Milda PRANSKEVIČIENĖ,
IĮ" Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Farmacinės kompozicijos, apimančios ZD6474 |
| PHARMACEUTICAL COMPOSITIONS COMPRISING ZD6474 |
| Payment date | Validity (years) | Amount | |
| 2020-04-21 | 16 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2021-05-18 |